1 / 24

BREAST CONSERVATIVE THERAPY

BREAST CONSERVATIVE THERAPY. Dr Shailesh Puntambekar Consulting onco surgeon Associate professor , department of surgery, KEM Hospital, Pune, India. In the good old days we made a clean breast of malignant disease.In the modern era there is no TIT for T(h)AT. HISTORY.

maude
Download Presentation

BREAST CONSERVATIVE THERAPY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BREAST CONSERVATIVE THERAPY • Dr Shailesh Puntambekar • Consulting onco surgeon • Associate professor , department of surgery, KEM Hospital, Pune, India

  2. In the good old days we made a clean breast of malignant disease.In the modern era there is no TIT for T(h)AT

  3. HISTORY • Halstead radical mastectomy • Extended radical mastectomy • Modified radical mastectomy • Breast conservation therapy

  4. BCS:Why? • Ca Breast is a local manifestation of a systemic disease.Local radicality does not change survival • Cosmetic Considerations • Preservation of the nipple ,an important sensate focus

  5. Mastectomy is a socially devastating surgery for the downtrodden Indian woman and signals an end to her married life.The relevance of BCS in the Indian scene cannot be overemphasised.

  6. INDICATIONS • Stage I & II • ? Stage III

  7. CONTRAINDICATIONS • Pregnancy • Multicentric disease • Diffuse indeterminate micro-calcification • Previous RT • Large tumour/ breast ratio • Collagen vascular disease • Large breast size • Central tumour

  8. Small Breast Realities • In a small breast not much to achieve in cosmesis • Recurrence comes as Cancer en Cuirasse

  9. POST MRM NO RADIOTHERAPY • SATELLITE NODULES OVER THE CHEST WALL • NO TREATMENT IS EFFECTIVE • PALIATIVE INTENT OF RADIOTHERAPY

  10. Large Breast Realities • In a large breast recurrences not easily diagnosed • A recurrence is viewed as a second primary

  11. SPECIAL CONSIDERATIONS • Family history • Primary tumour histology • Margin evaluation • Extensive intraductal component

  12. METHODS • Lumpectomy +Axillary dissection +RT • Lumpectomy+SLN biopsy +RT • QUART- Quadrantectomy +Axillary dissection +RT • CTART- Chemotherapy +RT

  13. Axillary Dissection • Better control of locoregional recurrence • Accurate staging of disease • To decide adjuvant therapy • Prognosis

  14. GUIDELINES OF SURGERY • Incision • Technique • Closure • Axillary Dissection

  15. NEW INVESTIGATION MODALITIES • MRI • Intra-op ultra-sound • Touch preparation cytology • Percutaneous needle biopsy

  16. NEW TECHNIQUES OF TUMOUR MANAGEMENT • Radio Frequency Ablation –RFA • Cryosurgery • Focused Ultrasound • Percutaneous tumour extraction

  17. ROLE OF NEOADJUVANT • Induction chemotherapy • Drugs • Selection and monitoring of induction chemotherapy patients

  18. SEQUENCING OF CHEMOTHERAPY AND RT • 6 Cycles of CMF followed by RT • RT followed by 6 cycles of CMF • 3 Cycles of CMF followed by RT followed by 3 cycles of CMF (sandwich therapy)

  19. RADIOTHERAPY IN BCT • Intraoperative radiotherapy • Post operative radiotherapy • Brachytherapy

  20. SPECIAL CASES • Hereditory breast cancer • Macromastia • Occult breast cancer • Pregnancy • Bilateral breast cancer

  21. BCT / MRM T1 & T2 TUMOUR CONTROL RATE 5 YR RELAPSE FREE SURVIVAL RECURRANCE ONLY CONS SURGERY CONS SURGERY + RT 80 TO 90 % 70 TO 88 % 15 TO 40 % 2 TO 10 % RESULTS

  22. Newer Frontiers • Laparoscopic Axillary Dissection • Laparoscopic Int Mammary Clearance • Technically feasible • Clearance equal to standard technique • Acceptability only after it stands the test of time

  23. Thank You

More Related